Stay updated with breaking news from 62855j10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) has been assigned a consensus rating of “Hold” from the eight research firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating on […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its price objective boosted by research analysts at The Goldman Sachs Group from $28.00 to $31.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. The Goldman Sachs Group’s target price would suggest a potential upside of […]
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) shares shot up 2.7% on Thursday . The company traded as high as $18.76 and last traded at $18.73. 139,980 shares were traded during mid-day trading, a decline of 73% from the average session volume of 523,469 shares. The stock had previously closed at $18.24. Wall Street […]
Piper Sandler initiated coverage on shares of Myriad Genetics (NASDAQ:MYGN – Free Report) in a research note released on Thursday morning, Benzinga reports. The firm issued a neutral rating and a $23.00 price target on the stock. A number of other analysts have also weighed in on MYGN. StockNews.com upgraded shares of Myriad Genetics from […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided EPS guidance of -0.330–0.280 for the period, compared to the consensus EPS estimate of -0.300. The company issued revenue guidance of $747.0 million-$753.0 million, compared to the consensus revenue estimate of $750.9 million. […]